Retraction: TGFβ1signaling via aVβ6integrin (2004)
Kracklauer, Martin P, Schmidt, Christian, Sclabas, Guido M
No abstract available.
TGFβ1signaling via αVβ6integrin (2003)
Kracklauer, Martin P, Schmidt, Christian, Sclabas, Guido M
Abstract Background Transforming growth factor β 1 (TGFβ 1 ) is a potent inhibitor of epithelial cell growth, thus playing an important role in tissue homeostasis. Most carcinoma cells exhibit a...
First anniversary of Molecular Cancer: achievements and future goals (2003)
Deora, Arun B, Luettich, Karsta, Schmidt, Christian, Sclabas, Guido M
Abstract Molecular Cancer has been launched for one year now. Here, we describe achievements of the past year and future goals of the journal.
Frequently asked questions about Molecular Cancer (2003)
Lüttich, Karsta, Schmidt, Christian, Sclabas, Guido M
Abstract Molecular Cancer is as a forum for cutting edge cancer-related papers. This editorial will answer frequently asked question about this open-access and on-line journal as well as its...
Frequently asked questions about Molecular Cancer
Lüttich, Karsta, Schmidt, Christian, Sclabas, Guido M
Molecular Cancer is as a forum for cutting edge cancer-related papers. This editorial will answer frequently asked question about this open-access and on-line journal as well as its publisher BioMed...
First anniversary of Molecular Cancer: achievements and future goals
Deora, Arun B, Luettich, Karsta, Schmidt, Christian, Sclabas, Guido M
Molecular Cancer has been launched for one year now. Here, we describe achievements of the past year and future goals of the journal.
NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity
Fujioka, Shuichi, Niu, Jiangong, Schmidt, Christian, Sclabas, Guido M., Peng, Bailu, Uwagawa, Tadashi, ...
Nuclear factor κB (NF-κB) and activator protein 1 (AP-1) transcription factors regulate many important biological and pathological processes. Activation of NF-κB is regulated by the inducible...
Yokoi, Kenji, Kim, Sun-Jin, Thaker, Premal, Yazici, Sertac, Nam, Do-Hyun, He, Junqin, ...
Although gemcitabine has been accepted as the first-line chemotherapeutic reagent for advanced pancreatic cancer, improvement of response rate and survival is not sufficient and patients often...
Frequently asked questions about Molecular Cancer
Lüttich, Karsta, Schmidt, Christian, Sclabas, Guido M
Molecular Cancer is as a forum for cutting edge cancer-related papers. This editorial will answer frequently asked question about this open-access and on-line journal as well as its publisher BioMed...
First anniversary of Molecular Cancer: achievements and future goals
Deora, Arun B, Luettich, Karsta, Schmidt, Christian, Sclabas, Guido M
Molecular Cancer has been launched for one year now. Here, we describe achievements of the past year and future goals of the journal.
NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity
Fujioka, Shuichi, Niu, Jiangong, Schmidt, Christian, Sclabas, Guido M., Peng, Bailu, Uwagawa, Tadashi, ...
Nuclear factor κB (NF-κB) and activator protein 1 (AP-1) transcription factors regulate many important biological and pathological processes. Activation of NF-κB is regulated by the inducible...
Yokoi, Kenji, Kim, Sun-Jin, Thaker, Premal, Yazici, Sertac, Nam, Do-Hyun, He, Junqin, ...
Although gemcitabine has been accepted as the first-line chemotherapeutic reagent for advanced pancreatic cancer, improvement of response rate and survival is not sufficient and patients often...